These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 6358621)
1. [Can diabetic nephropathy be prevented?]. Viberti GC; Wiseman M; Mackintosch D; Keen H Journ Annu Diabetol Hotel Dieu; 1983; ():79-88. PubMed ID: 6358621 [No Abstract] [Full Text] [Related]
2. The development of nephropathy in insulin-dependent diabetes mellitus is associated with poor glycemic control. Feldt-Rasmussen B Transplant Proc; 1994 Apr; 26(2):371-2. PubMed ID: 8171466 [No Abstract] [Full Text] [Related]
3. Renal function changes in diabetes. Mogensen CE Diabetes; 1976; 25(2 SUPPL):872-9. PubMed ID: 971791 [TBL] [Abstract][Full Text] [Related]
5. Treatment of diabetic nephropathy: a rational approach based on its pathophysiology. Tuttle KR; DeFronzo RA; Stein JH Semin Nephrol; 1991 Mar; 11(2):220-35. PubMed ID: 1674623 [No Abstract] [Full Text] [Related]
6. The point of no-return for the diabetic kidney is beyond clinical proteinuria. Selam JL; Giraud P; Mirouze J Diabet Med; 1984 Sep; 1(3):242. PubMed ID: 6242808 [No Abstract] [Full Text] [Related]
7. Progression of diabetic nephropathy in type 1 diabetic patients. Najafian B; Mauer M Diabetes Res Clin Pract; 2009 Jan; 83(1):1-8. PubMed ID: 19070384 [TBL] [Abstract][Full Text] [Related]
8. [Prediction, screening and treatment of renal complications of diabetes]. Marre M; Larger E Rev Prat; 2001 Oct; 51(16):1769-75. PubMed ID: 11795120 [TBL] [Abstract][Full Text] [Related]
9. Comments on a pilot study to test the effect of pulsatile insulin infusion on type 1 diabetes mellitus patients with proteinuria. Leinung MC Metabolism; 2010 May; 59(5):763-4; author reply 764-5. PubMed ID: 20206368 [No Abstract] [Full Text] [Related]
11. Diabetic nephropathy--what does it cause to develop? de Jong PE Neth J Med; 1988 Oct; 33(3-4):101-5. PubMed ID: 3067096 [No Abstract] [Full Text] [Related]
12. [The kidney as a target organ in diabetic patients with arterial hypertension]. Viberti G Drugs; 2003; 63 Spec No 1():31-7. PubMed ID: 12708880 [TBL] [Abstract][Full Text] [Related]
13. Controversies on the prevention of diabetic nephropathy. Chiarelli F; Verrotti A; Basciani F; di Ricco L; Sabatino G; Morgese G J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():365-9. PubMed ID: 9642666 [TBL] [Abstract][Full Text] [Related]
14. Prevention and treatment of diabetic nephropathy. Wittmann I; Molnár GA; Degrell P; Wagner Z; Tamaskó M; Laczy B; Brasnyó P; Wagner L; Nagy J Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S36-42. PubMed ID: 15955373 [TBL] [Abstract][Full Text] [Related]
15. Prevention of diabetic nephropathy: markers of disease and perspectives for intervention. Viberti GC; Wiseman MJ; Bending JJ Diabet Med; 1986 May; 3(3):208-11. PubMed ID: 2951170 [No Abstract] [Full Text] [Related]
16. [Predicting diabetic nephropathy]. Mogensen CE; Christensen CK Journ Annu Diabetol Hotel Dieu; 1984; ():333-49. PubMed ID: 6399537 [No Abstract] [Full Text] [Related]
17. The patterns of proteinuria in diabetes mellitus. Relevance to pathogenesis and prevention of diabetic nephropathy. Viberti G; Keen H Diabetes; 1984 Jul; 33(7):686-92. PubMed ID: 6376224 [No Abstract] [Full Text] [Related]
18. [Ischemic nephropathy in patients with diabetes mellitus]. Shamkhalova MSh; Klefortova II; Zaĭtseva NV; Shestakova MV Ter Arkh; 2007; 79(4):76-80. PubMed ID: 17564025 [No Abstract] [Full Text] [Related]
19. The renoprotective action of angiotensin-converting enzyme inhibitors in diabetes. Ruggenenti P; Remuzzi G Exp Nephrol; 1996; 4 Suppl 1():53-60. PubMed ID: 9001898 [TBL] [Abstract][Full Text] [Related]
20. [Can diabetic nephropathy be prevented? Or what is the point of no return?]. Grimaldi A; Baumelou A Ann Med Interne (Paris); 1987; 138(7):483-5. PubMed ID: 3326450 [No Abstract] [Full Text] [Related] [Next] [New Search]